...
首页> 外文期刊>Expert opinion on pharmacotherapy >The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth.
【24h】

The use of progesterone and other progestational agents to prevent spontaneous preterm labour and preterm birth.

机译:使用黄体酮和其他原始药剂以防止自发早产和早产。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Preterm birth is the major cause of perinatal mortality and morbidity in the developed world, making a huge impact on healthcare costs. There is accumulating evidence that the prophylactic use of progestagens is able to reduce significantly the incidence of low birth weight and preterm birth. OBJECTIVES: to emphasise the importance of preterm birth; to review the role of progesterone in inducing myometrial quiescence which prevent preterm labour and preterm birth; to review the published literature and planned future research on the use of progestagens for the prevention of preterm birth. METHODS: A review of the published literature using accepted search engines. RESULTS/CONCLUSIONS: Progestagens have been demonstrated to reduce the incidence of low birth weight and preterm birth. Many questions remain unanswered, particularly the long-term safety concerns and also whether the use of progestagens results in improved neonatal and childhood outcomes.
机译:背景:早产是发达国家围产期死亡率和发病率的主要原因,对医疗成本产生了巨大影响。 积累了证据表明孕激素的预防用途能够明显减少出生体重和早产的发病率。 目标:强调早产的重要性; 审查黄体酮在诱导肌瘤静脉中的作用,以防止早产和早产的肌瘤静脉; 审查发表的文献和计划未来关于使用孕激素预防早产的研究。 方法:使用已接受的搜索引擎审查已发表的文献。 结果/结论:已证明孕激素降低出生体重和早产的发病率。 许多问题仍未得到答复,特别是长期安全问题以及普利涎代胶的使用导致新生儿和儿童成果的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号